Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Preparing Immunocompromised Patients for Risks of Traveling Abroad

Susan Bernstein  |  Issue: September 2015  |  September 15, 2015

Immunocompromised patients are advised to avoid certain live vaccines, including Ty21a typhoid, measles-mumps-rubella, yellow fever and Bacillus Calmette Guérin (BCG) tuberculosis. These vaccines are recommended for the general population prior to travel to at-risk regions. Certain destinations may simply be off limits for some patients. “Because of the risk of yellow fever in certain parts of the African continent and the inability of immunocompromised patients to receive the yellow fever vaccine, these travelers may want to avoid those areas completely,” says Dr. Adalja.

If patients are planning international travel, they need to know the risks of both infections and preventive measures. For example, the anti-malarial drug chloroquine may decrease the bioavailability of methotrexate, which is a widely used therapy for RA and other rheumatic diseases.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Centers for Disease Control and Prevention offers information and specific vaccine recommendations for immunocompromised travelers on its website, including the Yellow Book for physicians. This information can help rheumatologists stay informed so they can vaccinate or advise their patients prior to travel, says Dr. Lockshin.

“I try to stay reasonably on top of what’s happening in areas where patients are going,” he says. “I usually go on the CDC site or suggest that my patients do so if they are going to any exotic areas.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Guidelines for vaccinations for immunocompromised patients may change, and new outbreaks of infectious disease in unexpected regions may occur with little warning. Establishing open communication with patients at the beginning of the relationship is important, he says. “I get to know people I am treating, and when I take their first medical history, I get an idea of how much they may travel. There are always those people who do a lot of international travel. I think few, if any, of my patients would travel without having that conversation with me first. We just have that kind of relationship.”

Rheumatologists should suggest that their patients review online travel risk information before booking any international trip, so they are aware of their particular infection risks, says Dr. Adalja.

“The CDC travel website is a great source. Additionally, they may want to meet with an infectious disease physician prior to travel in order to ensure that they take the appropriate precautions,” he says. Many people simply do not know current infection risks, which may rise quickly. “Travel-related illnesses are underappreciated. Many U.S.-based physicians do not have great knowledge about them. A proactive approach in which patients are counseled about the risks they face when immunosuppressants are used would go a long way toward empowering patients.”

Preventive Action

Before planning any travel, all patients should be up to date with the vaccinations they can take, such as hepatitis A and B, and pneumococcus, says Dr. Lockshin.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Conditions Tagged with:ClinicalDiseaseoutbreakspatient carerheumatologistsrisk

Related Articles

    Barbara Volcker Center Marks 20 Years of Research & Clinical Work

    January 19, 2018

    Although two decades have ticked by, rheumatologist Michael Lockshin, MD, MACR, still remembers the enlightening nature of many conversations he had with his curious and persistent patient Barbara Volcker, the wife of former U.S. Federal Reserve Chairman Paul Volcker. “The conversations we had at that time led to the mission of the Barbara Volcker Center,”…

    Yellow Card for the Yellow Card

    May 13, 2021

    Independence Day. I can’t wait. Generally, it’s not a holiday that carries a lot of meaning for me. Having grown up in New York and Boston, the smaller firework displays that take place in Baltimore fail to impress. Also, as a program director, the holiday falls in the middle of the new fellows’ first week…

    Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians

    September 1, 2014

    Infectious Diseases Society of America recommends both physician groups educate patients, household members on importance of vaccines

    The History of the American College of Rheumatology Image Library

    October 19, 2020

    Late-night gatherings; long hours of avid discussion weighing the merits of resolution quality, light, hues and tones; and camaraderie among members forged through a shared interest in maintaining the highest fidelity to their craft and profession—these are among the vivid memories of those who participated in the early years of building what is today known…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences